Loading...
CAR-T cell therapy in ovarian cancer: from the bench to the bedside
Ovarian cancer (OC) is the most lethal gynecological malignancy and is responsible for most gynecological cancer deaths. Apart from conventional surgery, chemotherapy, and radiotherapy, chimeric antigen receptor-modified T (CAR-T) cells as a representative of adoptive cellular immunotherapy have rec...
Saved in:
| Published in: | Oncotarget |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Impact Journals LLC
2017
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5610030/ https://ncbi.nlm.nih.gov/pubmed/28969098 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19929 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|